Use of prasugrel and clinical outcomes in African-American patients treated with percutaneous coronary intervention for acute coronary syndromes.
Michela FaggioniUsman BaberJaya ChandrasekharSamantha SartoriWilliam WeintraubSunil V RaoBirgit VogelBimmer ClaessenAnnapoorna S KiniMark B EffronZhen GeStuart KellerCraig StraussClayton SnyderCatalin TomaSandra WeissMelissa AquinoBrian BakerAnthony DefrancoSameer BansilalBrent MuhlesteinSamir R KapadiaStuart PocockKanhaiya L PoddarTimothy D HenryRoxana MehranPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2019)
Despite higher risk clinical presentation and worse 1-year ischemic outcomes, AA race was an independent predictor of lower prasugrel prescription in a contemporary population of ACS patients undergoing PCI.
Keyphrases
- percutaneous coronary intervention
- acute coronary syndrome
- african american
- st segment elevation myocardial infarction
- patients undergoing
- antiplatelet therapy
- acute myocardial infarction
- st elevation myocardial infarction
- coronary artery bypass grafting
- coronary artery disease
- coronary artery bypass
- ischemia reperfusion injury
- type diabetes
- adipose tissue
- cerebral ischemia
- heart failure
- subarachnoid hemorrhage
- oxidative stress
- blood brain barrier
- weight loss